In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 13 (4) , 279-287
- https://doi.org/10.1016/0145-2126(89)90064-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Oncogene expression in myelopoiesisThe International Journal of Cell Cloning, 1987
- Expression of a transfected human c-myconcogene inhibits differentiation of a mouse erythroleukaemia cell lineNature, 1986
- Expression of c-myc changes during differentiation of mouse erythroleukaemia cellsNature, 1984
- Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemiaNature, 1984
- Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factorCell, 1983
- Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolution.Molecular and Cellular Biology, 1983
- Induction of Hemoglobin Accumulation in Human K562 Cells by Hemin Is ReversibleScience, 1981
- INDUCERS OF ERYTHROID-DIFFERENTIATION IN K562 HUMAN-LEUKEMIA CELLS1981
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975